CDRxAbs:抗体小分子结合物与计算设计的目标结合协同作用
Jingzhou Wang1,2,3, Aiden J Aceves1,4, Nicholas J Friesenhahn2
1Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, United States.
Protein engineering, design & selection : PEDS
|March 21, 2025
概括
我们开发了CDR扩展抗体 (CDRxAbs),这是一种新型分子药物. 这些生物结合物增强了小分子结合亲和力和对标的特异性.
科学领域:
- 生物结合化学的化学
- 计算式蛋白质设计
- 分子识别分子识别
背景情况:
- 生物结合物通过结合分子优势提供了精细的治疗作用.
- 目前在优化小分子疗法的结合亲和性和特异性方面存在局限性.
研究的目的:
- 引入CDR扩展抗体 (CDRxAbs) 作为一种新型分子识别剂.
- 证明CDRxAbs提高小分子结合亲和力和特异性的能力.
主要方法:
- 使用计算式蛋白质设计与完整的原子模拟.
- 将小分子集成到抗体结合接口中.
- 为概念验证设计和优化纳米体-生物联体.
主要成果:
- 对针对蛋白质标的纳米体 - 生物联体获得了>20倍的亲和力改善.
- 证明了结合动力学和蛋白质稳定性的逐步优化.
- 在概念验证研究中验证了CDRxAb概念.
结论:
- CDRxAbs代表了一种新的方法来增强基于小分子的治疗方法.
- 这种方法有望扩大分子识别剂的化学和目标空间.
- 与单独的小分子相比,CDRxAbs提供了更好的结合亲和力和特异性.
更多相关视频
11:02Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
7.7K
09:39Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF
Published on: September 17, 2019
6.7K
相关概念视频
Antibody Actions
1.0K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.0K
Affinity and Avidity
35.7K
Overview
35.7K
